The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMS 2023 | Practical considerations for treating elderly and frail patients with multiple myeloma
Hira Mian, MD, McMaster University, Hamilton, Canada, discusses the standard of care (SOC) for elderly and frail patients with multiple myeloma, and comments on the importance of optimizing treatment approaches in order to improve patient quality of life (QoL). Dr Mian further elaborates on the role of triplet regimens in this patient population, highlighting the importance of mitigating treatment-related toxicities. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
